Key facts
- Arbutus Medical’s last known valuation is $4.1M (Jul 2020).
- It has raised $13.2M; the latest was Later Stage VC ($6.8M) in Feb 2026.
- Notable investors include Keiretsu Forum, Crédit Mutuel Equity, Scale Good Fund, Sorenson Impact Foundation, Life Sciences BC — 34 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 34 names
- ·Watchlist + deal alerts for Arbutus Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Arbutus Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arbutus Medical
Developer of orthopedic power tools designed to help doctors perform surgeries. The company focuses on sterile-packed orthopedic procedure kits such as the HEX and PRO drill kit, skeletal traction tools, and more, enabling surgeons to save time and cost and improve access for patients.
- Sector
- Healthcare
- HQ
- Vancouver, Canada
- Founded
- 2014
- Employees
- 30
- Website
- arbutusmedical.com/
- Ownership
- Privately Held (backing)
Arbutus Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arbutus Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arbutus Medical in its N-PORT filings yet. We sweep new filings monthly.